oxazoles has been researched along with Pneumonia in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (33.33) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 4 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ruth, MM; van Ingen, J | 1 |
Fu, J; Hou, G; Liu, L; Shetty, S; Wang, Q; Zhou, X | 1 |
Choi, S; Hong, SK; Im, W; Lee, K; Lee, Y; Yong, D | 1 |
Amour, A; Baldwin, IR; Cooper, AW; Deakin, AM; Down, K; Felton, LM; Guntrip, SB; Hamblin, JN; Hardy, C; Harrison, ZA; Jones, KL; Jones, P; Keeling, SE; Le, J; Livia, S; Lucas, F; Lunniss, CJ; Parr, NJ; Robinson, E; Rowland, P; Smith, S; Thomas, DA; Vitulli, G; Washio, Y | 1 |
Krey, WD | 1 |
Buogo, A; Perrotta, P | 1 |
6 other study(ies) available for oxazoles and Pneumonia
Article | Year |
---|---|
New insights in the treatment of nontuberculous mycobacterial pulmonary disease.
Topics: Anti-Bacterial Agents; Clofazimine; Humans; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Organophosphates; Oxazoles; Pneumonia; Treatment Outcome | 2017 |
HDAC6 inhibition blocks inflammatory signaling and caspase-1 activation in LPS-induced acute lung injury.
Topics: Acetylation; Acute Disease; Acute Lung Injury; Animals; Anti-Inflammatory Agents; Carbamates; Caspase 1; Cytokines; Enzyme Activation; Histone Deacetylase 6; Histone Deacetylase Inhibitors; Inflammasomes; Lipopolysaccharides; Lung; Male; Mice; Mice, Inbred C57BL; NF-kappa B; Oxazoles; Pneumonia; Signal Transduction; Tubulin | 2019 |
In vitro activity of tedizolid against gram-positive bacteria in patients with skin and skin structure infections and hospital-acquired pneumonia: a Korean multicenter study.
Topics: Anti-Bacterial Agents; Asian People; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Hospitals; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Organophosphates; Oxazoles; Pneumonia; Republic of Korea; Skin; Skin Diseases | 2015 |
Optimization of Novel Indazoles as Highly Potent and Selective Inhibitors of Phosphoinositide 3-Kinase δ for the Treatment of Respiratory Disease.
Topics: Administration, Inhalation; Animals; Asthma; Female; Humans; Indazoles; Indoles; Isoenzymes; Male; Microsomes; Molecular Docking Simulation; Ovalbumin; Oxazoles; Phosphoinositide-3 Kinase Inhibitors; Piperazines; Pneumonia; Pulmonary Disease, Chronic Obstructive; Rabbits; Rats; Rats, Sprague-Dawley; Respiratory Tract Diseases; Stereoisomerism; Structure-Activity Relationship; Sulfonamides; Th2 Cells | 2015 |
[Experiences with a combined treatment with ampicillin and dicloxacillin in children].
Topics: Adolescent; Ampicillin; Bronchopneumonia; Child; Child, Preschool; Dicloxacillin; Female; Humans; Infant; Infant, Newborn; Infections; Male; Mucous Membrane; Osteomyelitis; Oxazoles; Penicillins; Pneumonia; Skin Diseases, Infectious; Time Factors | 1970 |
[Ampicillin-dicloxacillin association in acute and chronic bronchopneumopathies. Clinical study].
Topics: Acute Disease; Adolescent; Adult; Ampicillin; Bronchitis; Bronchopneumonia; Chronic Disease; Dicloxacillin; Drug Synergism; Female; Humans; Lung Diseases; Male; Middle Aged; Oxazoles; Penicillins; Pleuropneumonia; Pneumonia | 1971 |